BioSpace News Archive

UCB, a global biopharmaceutical company, today announced new interim results from the BE BRIGHT open-label extension (OLE) study evaluating the long-term safety, tolerability and efficacy of bimekizumab through to two years in adult patients with moderate to severe plaque psoriasis who completed one of the three Phase 3 pivotal studies.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today presented a new analysis of five-year results that shows its novel gene therapy, PTC-AADC, leads to profound improvements in children with aromatic L-Amino acid decarboxylase (AADC) deficiency, a previously intractable, fatal and devastating rare disorder of the central nervous system

BioAtla, Inc. today announced that it has entered into stock purchase agreements with a group of institutional investors in connection with a private placement of its common stock.

AgNovos Healthcare, LLC and Asahi Kasei Pharma Corporation announced that the companies have entered into an exclusive option agreement for the commercialization of AgNovos’ AGN1 LOEP Hip Kit in Japan.

Sporos Bioventures, LLC today announced the appointment of Amit Rakhit, M.D., M.B.A. as chief executive officer.

Syros Pharmaceuticals today announced that the first patient has been dosed in the dose confirmation study of SY-2101, a novel oral form of arsenic trioxide (ATO).

Endologix Initiates Randomized Study of ALTO ® Abdominal Stent Graft System

Humanigen, Inc. today announced a presentation of the results from the Company’s randomized, double-blind, placebo-controlled LIVE-AIR Phase 3 study at IDWeek 2021

Surmodics, Inc. today announced the successful first clinical uses of of the Sublime™ Radial Access .018 RX PTA Dilatation Catheter.

PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan